Logo

Aussie Hospital Buys Partek's Genomics Suite Software to Study Cancer, Metabolic Disorders

Dec 15, 2006
NEW YORK (GenomeWeb News) — The Women’s & Children’s Hospital in Adelaide, Australia, has bought Partek’s data-handling software, Partek said today.  
 
Partek said the Department of Genetic Medicine at the Women’s and Children’s Hospital will use the Partek Genomics Suite software to analyze data in studies of cancer, birth defects, and metabolic disorders.
 
Missouri-based Partek is a genomics software developer specializing in an Affymetrix GeneChip-compatible platform that is used to identify and quantify data patterns.
 
Partek said the software handles data from “genomic and proteomic studies, high throughput screening campaigns and computer aided drug design.”
 
Financial terms of the sale were not released.

Filed under

Informatics
Breaking News
The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.